Below are the most recent publications written about "Crohn Disease" by people in Profiles.
-
Dixit D, Ruiz NC, Shen S, Daneshmand A, Rodriguez VI, Qian S, Neal D, Rampertab SD, Zimmermann EM, Kamel AY. Mucosal Healing Among Black and White Patients With Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2024 Aug 01; 15(8):e00737.
-
Rashid M, Rashid R, Saroya S, Deverapalli M, Brim H, Ashktorab H. Saffron as a Promising Therapy for Inflammatory Bowel Disease. Nutrients. 2024 Jul 20; 16(14).
-
Gravina AG, Panarese I, Trotta MC, D'Amico M, Pellegrino R, Ferraraccio F, Galdiero M, Alfano R, Grieco P, Federico A. Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity? World J Gastroenterol. 2024 Mar 07; 30(9):1132-1142.
-
Casertano M, Trotta MC, Cenni S, Creoli M, Miele E, Martinelli M, Lepre CC, Russo M, Alfano R, D'Amico M, Strisciuglio C. Infliximab therapy decreases the expression of serum and faecal miR-126 and miR-20a in paediatric Crohn's disease: A?pilot study. Acta Paediatr. 2024 03; 113(3):590-597.
-
Lin WC, Tai WC, Chang CH, Tu CH, Feng IC, Shieh MJ, Chung CS, Yen HH, Chou JW, Wong JM, Liu YH, Huang TY, Chuang CH, Tsai TJ, Chiang FF, Lu CY, Hsu WH, Yu FJ, Chao TH, Wu DC, Ho AS, Lin HH, Feng CL, Wu KL, Wong MW, Tung CC, Lin CC, Chen CC, Hu HM, Lu LS, Wang HS, Wu IC, Kuo HY, Wu JF, Yao Shih H, Ni YH, Tang SL, Chen PH, Wei SC. Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study. Inflamm Bowel Dis. 2023 11 02; 29(11):1730-1740.
-
Chakraborty R, Maltz MR, Del Castillo D, Tandel PN, Messih N, Anguiano M, Lo DD. Selective Targeting of Tumour Necrosis Factor Receptor 1 Induces Stable Protection from Crohn's-Like Ileitis in TNF?ARE Mice. J Crohns Colitis. 2022 Jul 14; 16(6):978-991.
-
M'Koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina (Kaunas). 2022 Apr 21; 58(5).
-
Yamamoto-Furusho JK, Parra-Holgu?n NN, Juliao-Ba?os F, Puentes F, L?pez R, Bosques-Padilla F, Torres EA, Nieves-Jimen?z H, Veitia-Vel?squez GR, Jara-Alba ML, Bautista S, Pi?ol-Jimenez FN, Salgado-Rosado P, Villa-Ovalles KC, Abreu-Martinez YA, Borges Z, Davila-Bedoya S, Otoya-Moreno G, Iad?-Vergara B. Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean. Medicine (Baltimore). 2022 Jan 21; 101(3):e28624.
-
Torres EA, Torres-Cintron M, Velazquez S, Vendrell R, Del Valle A, P?rez CM. Prevalence of Inflammatory Bowel Diseases in Puerto Rico: A Health Care Claims Analysis of an Insured Population. P R Health Sci J. 2021 Sep; 40(3):103-109.
-
Mu?iz-Camacho LA, Negr?n-Quintana FI, Ramos-Burgos LA, Cruz-Cruz JJ, Torres EA. Knowledge, Perception, and Use of Cannabis Therapy in Patients with Inflammatory Bowel Disease. P R Health Sci J. 2021 Sep; 40(3):110-114.